Incannex Healthcare Inc. (IXHL)
Nasdaq: IXHL · Pharmaceutical Preparations · filing with the SEC since 2021
Who runs Incannex Healthcare Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Latham Joel
CEO and President. First filing Dec 2023, latest Nov 14, 2025, 0 filings in all.
Officers reporting now
2
of 6 people with a filing in the last fifteen months
Directors reporting now
4
9 people on the record since 2023
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Latham Joel | CEO and President | Dec 2023 | Nov 14, 2025 | none |
| Swan Joseph | CFO, Treasurer and Secretary | Dec 2023 | Nov 14, 2025 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Anastassov George | director | Dec 2023 | Nov 14, 2025 | none |
| Clark Robert | director | Dec 2023 | Nov 14, 2025 | none |
| Valentine Troy | director | Dec 2023 | Nov 14, 2025 | none |
| Widdows Peter | director | Dec 2023 | Nov 14, 2025 | none |
Earlier names on the record3, newest filing first
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.